Clinical Trials

AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

  Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience AliveCor, maker of an innovative, FDA-cleared, personal electrocardiogram (ECG) technology, has partnered with the Jefferson Narcotic Addiction Rehabilitation…

Read More